{2 (0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]) / 1 (0.8 ML adalimumab-adaz... — RxCUI 2641671
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.
- It calms inflammation in conditions like rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis. Whi...
- It goes under the skin of your thigh or abdomen. Rotate sites and avoid tender, bruised or red skin. You can let it warm up for 15 to 30 minutes first, with the cap on. If you miss...
- Injection site redness, itching or pain is the most common. Colds, sinus infections, headache and rash are also common. These are usually mild.
- Call right away for fever, chills, cough or any sign of infection, since serious infections can happen. Also call for signs of allergic reaction, new nerve or vision problems, unus...
🕸️ Concept Web — How {2 (0.4 ML adalimumab-adaz 100 MG/ML Auto-Inject... Connects
RxCUI 2641671 Brand name pack · BPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Adalimumab
327361IN -
Adalimumab-adaz
2641642PIN
-
Adalimumab
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Hyrimoz
2641646BN
-
Hyrimoz
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Adalimumab Auto-Injector
1655725SCDF -
Adalimumab-adaz Auto-Injector
2648705SCDFP -
Adalimumab Injectable Product
1163691SCDG -
Adalimumab-adaz Injectable Product
2662733SCDGP -
Adalimumab Auto-Injector [Hyrimoz]
2641657SBDF -
Adalimumab-adaz Auto-Injector [Hyrimoz]
2658594SBDFP -
Hyrimoz Injectable Product
2641648SBDG -
Pack
746839DF - +1 more in this family
-
Adalimumab Auto-Injector
-
Clinical & branded drugs 6
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector
2641655SCD -
0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector
2641662SCD -
Adalimumab-adaz 100 MG/ML
2641643SCDC -
0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]
2641658SBD -
0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]
2641663SBD -
Adalimumab-adaz 100 MG/ML [Hyrimoz]
2641647SBDC
-
0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector
SCD · 2641655 -
0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector
SCD · 2641662 -
{2 (0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector) / 1 (0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector) } Pack
GPCK · 2641670 -
Adalimumab-adaz 100 MG/ML
SCDC · 2641643 -
Adalimumab Auto-Injector
SCDF · 1655725 -
Adalimumab-adaz Auto-Injector
SCDFP · 2648705 -
Adalimumab Injectable Product
SCDG · 1163691 -
Adalimumab-adaz Injectable Product
SCDGP · 2662733
Brand-Name Concepts
-
0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]
SBD · 2641658 -
0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]
SBD · 2641663 -
Adalimumab-adaz 100 MG/ML [Hyrimoz]
SBDC · 2641647 -
Adalimumab Auto-Injector [Hyrimoz]
SBDF · 2641657 -
Adalimumab-adaz Auto-Injector [Hyrimoz]
SBDFP · 2658594 -
Hyrimoz Injectable Product
SBDG · 2641648 -
Hyrimoz
BN · 2641646
📦 FDA Products & Package NDCs
14 products · 18 package NDCs
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 61314-0454-20 | 2 SYRINGE in 1 CARTON (61314-454-20) / .8 mL in 1 SYRINGE | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0454-36 | 3 SYRINGE in 1 CARTON (61314-454-36) / .8 mL in 1 SYRINGE | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0454-68 | 3 SYRINGE, GLASS in 1 CARTON (61314-454-68) / .8 mL in 1 SY... | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0473-20 | 2 SYRINGE in 1 CARTON (61314-473-20) / .4 mL in 1 SYRINGE | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0473-64 | 2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SY... | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0473-92 | 2 SYRINGE in 1 CARTON (61314-473-92) / .4 mL in 1 SYRINGE | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0476-64 | 2 SYRINGE, GLASS in 1 CARTON (61314-476-64) / .2 mL in 1 SY... | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0509-64 | 2 SYRINGE, GLASS in 1 CARTON (61314-509-64) / .1 mL in 1 SY... | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0517-36 | 3 KIT in 1 CARTON (61314-517-36) / 1 KIT in 1 KIT * 1 SYRI... | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 61314-0531-64 | 2 KIT in 1 CARTON (61314-531-64) / 1 KIT in 1 KIT * 1 SYRI... | HYRIMOZ | Sandoz Inc | 2023-07-01 |
| 83457-0100-01 | 2 SYRINGE in 1 CARTON (83457-100-01) / .4 mL in 1 SYRINGE | HYRIMOZ | Cordavis Limited | 2023-09-21 |
| 83457-0101-01 | 2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SY... | HYRIMOZ | Cordavis Limited | 2023-09-21 |
| 83457-0102-01 | 2 SYRINGE in 1 CARTON (83457-102-01) / .8 mL in 1 SYRINGE | HYRIMOZ | Cordavis Limited | 2023-09-21 |
| 83457-0103-01 | 2 SYRINGE, GLASS in 1 CARTON (83457-103-01) / .8 mL in 1 SY... | HYRIMOZ | Cordavis Limited | 2023-09-21 |
| 83457-0107-01 | 2 SYRINGE in 1 CARTON (83457-107-01) / .8 mL in 1 SYRINGE | HYRIMOZ | Cordavis Limited | 2023-12-15 |
| 83457-0108-01 | 2 SYRINGE, GLASS in 1 CARTON (83457-108-01) / .2 mL in 1 SY... | HYRIMOZ | Cordavis Limited | 2023-12-15 |
| 83457-0112-01 | 1 KIT in 1 CARTON (83457-112-01) * 2 SYRINGE in 1 CARTON /... | HYRIMOZ | Cordavis Limited | 2023-12-15 |
| 83457-0113-01 | 3 SYRINGE in 1 CARTON (83457-113-01) / .8 mL in 1 SYRINGE | HYRIMOZ | Cordavis Limited | 2023-12-15 |
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.